Amarin Corp Plc (AMRN)

[sts66]

They also had more adverse events way beyond flushing: more myopathy, which was 10 times more likely in Chinese participants compared with those of European descent; more bleeding, including gastrointestinal bleeding and bleeding in intracranial and other sites; more diabetes—new diabetes diagnoses were increased by a third. And very surprising and unexpected: There was also an excess of serious infections in the niacin group.

So lessee....it may cause an aneurysm, diabetes, or serious infection...and it does nothing to reduce CV risk....and it's still on sale?!?! Seriously, if data like this was around prior to approval, the drug maker wouldn't have even submitted an NDA! How can the FDA NOT recall niacin?!?

Hong Kong banned it in 2013:

http://www.info.gov.hk/gia/general/201301/21/P201301210396.htm

And so did the EMA:

http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON228751

So nobody in the developed world allows it to be sold, except the good old FDA - your tax money at (non)work.